Ursula McCurry

Ursula McCurry has a strong background in clinical operations and drug safety. Ursula is currently serving as the Senior Vice President of Clinical Operations at Imugene Limited, a position they have held since January 2022. Prior to that, they worked at Amunix Pharmaceuticals as the Vice President of Clinical Operations from October 2020 to January 2022.

From 2012 to 2020, Ursula held several roles at Genentech, including Associate Director of Clinical Operations from November 2017 to October 2020, Sr. Clinical Program Leader from August 2014 to November 2017, and Senior Clinical Trial Manager from June 2012 to August 2014.

Before their time at Genentech, Ursula worked at SuperGen as the Clinical Program Manager from July 2011 to June 2012, and as a Sr. CRA from August 2010 to July 2011. Ursula also spent five years at Exelixis, where they served as a Clinical Trial Manager from January 2008 to August 2010, Associate Director of Drug Safety from January 2006 to January 2008, and Sr. Manager of Drug Safety from October 2005 to January 2006.

Lastly, Ursula started their career at QLT Inc. as an Associate Director of Drug Safety from October 1996 to September 2005. Throughout their career, they have gained extensive experience in clinical operations and drug safety management.

Ursula McCurry began their education in 1996 at Huron University, where they pursued a Bachelor's degree in History which they successfully completed in 2001. Ursula later enrolled in Simon Fraser University in 1991 and completed their Master's degree there in 2005. Unfortunately, the field of study for their Master's degree is not provided.